科学家发现易被人忽视的癌症早期症状

2017-01-01 佚名 科技世界网

统计数据显示,只有2%的人遇到类似症状会去就医,其他人都是在病情逐渐加剧之后才会咨询专家。然而,癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。如果吞咽令你感到不舒服,并且随着时间的推移加重,一定要咨询专家。几乎每个人每天都会遇到折磨自身的可疑且不明原因的症状。研究人员指出,一些看似无害的症状可能表明癌症处于发展的初级阶段。统计数据显示,只有2%的人遇到类似症状会去就医,其

统计数据显示,只有2%的人遇到类似症状会去就医,其他人都是在病情逐渐加剧之后才会咨询专家。然而,癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。如果吞咽令你感到不舒服,并且随着时间的推移加重,一定要咨询专家。

几乎每个人每天都会遇到折磨自身的可疑且不明原因的症状。研究人员指出,一些看似无害的症状可能表明癌症处于发展的初级阶段。

统计数据显示,只有2%的人遇到类似症状会去就医,其他人都是在病情逐渐加剧之后才会咨询专家。然而,癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。

  1. 如果您定期会出现不明原因且令人不适的咳嗽,这可能表明你的肺部有某种问题。特别严重的咳嗽会带来疼痛和出血。

2.大便问题。

3.无法控制的持续性疼痛。服用药品也无济于事,并且随着时间的推移,人们开始习惯并且不重视它们。

4.身体上没有愈合的伤口,平均而言,小的损伤应该在三个星期内恢复,如果超过三个星期,需要就医。

5.皮肤硬结,特别是淋巴结部位,有必要去做超声波检查。

6.吞咽困难,这是一个不应该困扰你的自然过程。如果吞咽令你感到不舒服,并且随着时间的推移加重,一定要咨询专家。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-03 往日如昨

    继续学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-03 往日如昨

    癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-02 susice

    应该重视起来

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 Y—xianghai

    写的太单调乏味了,也很不专业。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 dhzzm

    有待进一步确认

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 thlabcde

    好东西学习了!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 Shirley_dai

    报纸上的吧

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1668678, encodeId=0c1b16686e803, content=<a href='/topic/show?id=914a5941660' target=_blank style='color:#2F92EE;'>#早期症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59416, encryptionId=914a5941660, topicName=早期症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed026379365, createdName=daviiliu, createdTime=Sat Aug 26 02:13:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802370, encodeId=595518023e0a8, content=<a href='/topic/show?id=acfae485578' target=_blank style='color:#2F92EE;'>#科学家发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74855, encryptionId=acfae485578, topicName=科学家发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Jul 21 09:13:00 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167624, encodeId=9e2616e62445, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:10:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167623, encodeId=bfd116e623c7, content=癌症早期阶段的治疗能够大大增加生存几率,并且能够使患者完全摆脱这一疾病。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Tue Jan 03 07:09:34 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167403, encodeId=418416e40319, content=应该重视起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Mon Jan 02 08:42:36 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167264, encodeId=c09416e26486, content=写的太单调乏味了,也很不专业。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Jan 01 15:52:46 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167258, encodeId=e6cd16e25828, content=有待进一步确认, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Sun Jan 01 15:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167236, encodeId=b82816e236d9, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sun Jan 01 12:55:56 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167226, encodeId=a4ad16e22659, content=报纸上的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90541990513, createdName=Shirley_dai, createdTime=Sun Jan 01 11:39:09 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167223, encodeId=03ea16e2237d, content=学习了,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419b1970835, createdName=刘翔翔, createdTime=Sun Jan 01 11:26:18 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 刘翔翔

    学习了,很实用

    0

相关威廉亚洲官网

广告:多发性骨髓瘤新药伊沙佐米出炉

误诊多发,多发性骨髓瘤是隐藏的高手 贫血、腰腿疼,这样的问题发生在老年人身上似乎不算稀奇,然而有一种血液肿瘤却悄悄地隐藏在这些不稀奇的症状背后,那就是多发性骨髓瘤。由于多发性骨髓瘤有着临床表现多样性的特点,因此漏诊、误诊的患者并不鲜见。。 发病率与年龄成正相关 提到多发性骨髓瘤,很多人感觉陌生,然而这一疾病的发病率却在血液系统恶性疾病中高居第2位,仅次

一个视频告诉你癌症放疗和化疗的区别?湖南省肿瘤医院专家详解

在肿瘤治疗的道路上,手术、放射治疗、化学治疗被称为“三板斧”,一直以来,放射治疗作为局部治疗方法,超过一半的肿瘤患者在治疗过程中都需要放射治疗进行参与,不仅可以治疗、控制癌症,还能减轻病人的痛苦,改善生活质量。“但现在仍然有很多患者对放疗不了解,常常谈放疗色变,错失最佳的放疗治疗时机。”湖南省肿瘤医院放疗科主任王晖教授说道。消灭肿瘤好帮手,放射治疗并不可怕王晖介绍,放疗全称是“放射治疗”,简单

小剂量阿司匹林为何能降低癌症的发生风险?

世界范围内癌症是造成死亡的首要病因,据估计未来几年癌症的发病率仍会上升。癌症的预防策略包括选择健康的生活方式,癌症高风险人群定期进行筛查等。近日,来自俄勒冈健康与科学大学(OHSU)与俄勒冈州立大学(OSU)的一项新的研究表明,小剂量阿司匹林有助于防止癌细胞的形成,并解释了这背后的机制,该研究结果已发表于AJP-Cell Physiology。研究显示,除了凝血外,血小板还可增加机体某些蛋白的水平

2016年终盘点:“神药”阿司匹林是否真的能够抵抗癌症?

医药史上的三大经典药物包括阿司匹林、青霉素和安定,其中药物阿司匹林在穿越了百年的风雨沉浮之后,终于焕发出了新的光彩。美国预防服务工作组在发表的最新威廉亚洲博彩公司 中指出,阿司匹林能够作为心血管疾病和结直肠癌的一级预防药物。关于阿司匹林与癌症的关系,众说纷纭,现在这个问题终于有定论了,这项最新威廉亚洲博彩公司 正式将阿司匹林作为预防结直肠癌的一级预防药物了。那么阿司匹林到底是否能够预防癌症,或者说是帮助机体抵御癌症呢?请

Cancer Res:樊代明院士阐述炎症与癌症关联

近日,中国工程院院士樊代明带领的研究小组在国际学术期刊Cancer Research上发表了一项最新研究进展,他们在这项研究中阐述了幽门螺旋杆菌诱导胃癌发生过程中,促炎症信号通路如何促进癌细胞的增殖和存活。该研究对于全面了解炎症与癌症之间的分子关联提供了一些新基础。炎症与癌症之间的分子关联目前还不甚明了,但是这种关联具有非常重要的病理学意义。IL-6及其他促炎症细胞因子激活的JAK2/STAT3